SLNSW-Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 ex...-TN_cdi_proquest_journals_2101739237

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

Full title: Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

Author/creator: Shen, Xian, Zhao, Bin.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2101739237

Language: English

Formats: Articles

Publishers: England: BMJ Publishing Group LTD

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101739237

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

    Record identifier

    TN_cdi_proquest_journals_2101739237

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101739237

    Share

    Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101739237

    Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

    Full title

    Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

    Author / Creator

    Shen, Xian ; Zhao, Bin

    Publisher

    England: BMJ Publishing Group LTD

    Journal title

    BMJ (Online), 2018, Vol.362, p.k3529-k3529

    Record Identifier

    TN_cdi_proquest_journals_2101739237

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    1333 Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Antineoplastic Agents, Immunological - administration & dosage Antineoplastic Agents, Immunological - therapeutic use Apoptosis B7-H1 Antigen - administration & dosage B7-H1 Antigen - therapeutic use Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - secondary Cell death Clinical medicine Clinical trials Humans Immunohistochemistry Immunosuppressive agents Immunotherapy Immunotherapy - methods Ligands Lung cancer Medical prognosis Meta-analysis Metastases Monoclonal antibodies Neoplasm Metastasis - drug therapy Neoplasms - drug therapy Nivolumab - administration & dosage Nivolumab - therapeutic use Patients PD-1 protein PD-L1 protein Pembrolizumab Programmed Cell Death 1 Receptor - drug effects Randomized Controlled Trials as Topic Survival Analysis Systematic review Targeted cancer therapy Treatment Outcome Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2101739237

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101739237

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections